Beam Therapeutics to Participate in 2024 Jefferies London Healthcare Conference [Yahoo! Finance]
Beam Therapeutics to Participate in 2024 Jefferies London Healthcare Conference
Beam Therapeutics: Additional BEAM-101 And ESCAPE Tech Data At ASH 2024 Makes This A Watch [Seeking Alpha]
Beam Therapeutics Inc. (NASDAQ: BEAM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock.
Beam Therapeutics upgraded to Outperform from Market Perform at Leerink [Yahoo! Finance]